Human cloning and embryonic stem cell research after Seoul

Permanent URI for this collection

Full text of the congressional hearing discussing the ethical issues raised by stem cell research recently conducted in Seoul, South Korea. Issues include human cloning for the purpose of producing human stem cells. [Opening statements] contains the opening statements of the congressional committee. [Battey] contains the testimony and prepared statement of James F. Battey, National Institutes of Health (NIH) Stem Cell Task Force chair. [Schwetz] contains the testimony and prepared statement of Bernard A. Schwetz, director of the Office for Human Research Protections, U.S. Department of Health and Human Services. [Pascal] contains the testimony and prepared statement of Chris B. Pascal, director of the Office of Research Integrity, U.S. Department of Health and Human Services. [Panel 1 questioning] contains the questioning of the first panel, consisting of Battey, Schwetz, and Pascal. [Chole] contains the testimony and prepared statement of stem cell researcher Dr. Richard A. Chole. [Norsigian] contains the testimony and prepared statement of Judy Norsigian, co-author of "Our Bodies Ourselves" and women's health advocate. [Brown] contains the testimony and prepared statement of patient advocate Joe Brown. [Beeson] contains the testimony and prepared statement of Diane Beeson, professor at California State University, East Bay. [Doerflinger] contains the testimony and prepared statement of pro-life advocate Richard M. Doerflinger. [Mathews] contains the testimony and prepared statement of Debra Mathews, scientist and bioethics scholar. [Panel 2 questioning] contains the questioning of the second panel, consisting of Chole, Norsigian, Brown, Beeson, Doerflinger, and Mathews. [Additional information (1)] contains additional information submitted. [Follow-up questions] contains follow-up questions for both panels. [Uniform requirements for manuscripts] contains the document "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication." [Hinxton Group] contains a statement from The Hinxton Group, "An International Consortium on Stem Cells, Ethics, and Law." [Values in conflict] contains the document "Values in Conflict: Public Attitudes on Embryonic Stem Cell Research." [Additional information (2)] contains additional information submitted.

Central Indiana Bioethics Portal

News

Comments or questions:
Amy J. Hatfield, M.L.S.,
IU School of Medicine
ajhatfie@iupui.edu

Browse

Recent Submissions

Now showing 1 - 10 of 18
  • Item
    Human cloning and embryonic stem cell research after Seoul. [Uniform requirements for manuscripts]
    (U.S. Government Printing Office, 2006-03-07) United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.
    Full text of the congressional hearing discussing the ethical issues raised by stem cell research recently conducted in Seoul, South Korea. Issues include human cloning for the purpose of producing human stem cells. [Opening statements] contains the opening statements of the congressional committee. [Battey] contains the testimony and prepared statement of James F. Battey, National Institutes of Health (NIH) Stem Cell Task Force chair. [Schwetz] contains the testimony and prepared statement of Bernard A. Schwetz, director of the Office for Human Research Protections, U.S. Department of Health and Human Services. [Pascal] contains the testimony and prepared statement of Chris B. Pascal, director of the Office of Research Integrity, U.S. Department of Health and Human Services. [Panel 1 questioning] contains the questioning of the first panel, consisting of Battey, Schwetz, and Pascal. [Chole] contains the testimony and prepared statement of stem cell researcher Dr. Richard A. Chole. [Norsigian] contains the testimony and prepared statement of Judy Norsigian, co-author of "Our Bodies Ourselves" and women's health advocate. [Brown] contains the testimony and prepared statement of patient advocate Joe Brown. [Beeson] contains the testimony and prepared statement of Diane Beeson, professor at California State University, East Bay. [Doerflinger] contains the testimony and prepared statement of pro-life advocate Richard M. Doerflinger. [Mathews] contains the testimony and prepared statement of Debra Mathews, scientist and bioethics scholar. [Panel 2 questioning] contains the questioning of the second panel, consisting of Chole, Norsigian, Brown, Beeson, Doerflinger, and Mathews. [Additional information (1)] contains additional information submitted. [Follow-up questions] contains follow-up questions for both panels. [Uniform requirements for manuscripts] contains the document "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication." [Hinxton Group] contains a statement from The Hinxton Group, "An International Consortium on Stem Cells, Ethics, and Law." [Values in conflict] contains the document "Values in Conflict: Public Attitudes on Embryonic Stem Cell Research." [Additional information (2)] contains additional information submitted.
  • Item
    Human cloning and embryonic stem cell research after Seoul. [Norsigian]
    (U.S. Government Printing Office, 2006-03-07) United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.; Norsigian, Judy
    Full text of the congressional hearing discussing the ethical issues raised by stem cell research recently conducted in Seoul, South Korea. Issues include human cloning for the purpose of producing human stem cells. [Opening statements] contains the opening statements of the congressional committee. [Battey] contains the testimony and prepared statement of James F. Battey, National Institutes of Health (NIH) Stem Cell Task Force chair. [Schwetz] contains the testimony and prepared statement of Bernard A. Schwetz, director of the Office for Human Research Protections, U.S. Department of Health and Human Services. [Pascal] contains the testimony and prepared statement of Chris B. Pascal, director of the Office of Research Integrity, U.S. Department of Health and Human Services. [Panel 1 questioning] contains the questioning of the first panel, consisting of Battey, Schwetz, and Pascal. [Chole] contains the testimony and prepared statement of stem cell researcher Dr. Richard A. Chole. [Norsigian] contains the testimony and prepared statement of Judy Norsigian, co-author of "Our Bodies Ourselves" and women's health advocate. [Brown] contains the testimony and prepared statement of patient advocate Joe Brown. [Beeson] contains the testimony and prepared statement of Diane Beeson, professor at California State University, East Bay. [Doerflinger] contains the testimony and prepared statement of pro-life advocate Richard M. Doerflinger. [Mathews] contains the testimony and prepared statement of Debra Mathews, scientist and bioethics scholar. [Panel 2 questioning] contains the questioning of the second panel, consisting of Chole, Norsigian, Brown, Beeson, Doerflinger, and Mathews. [Additional information (1)] contains additional information submitted. [Follow-up questions] contains follow-up questions for both panels. [Uniform requirements for manuscripts] contains the document "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication." [Hinxton Group] contains a statement from The Hinxton Group, "An International Consortium on Stem Cells, Ethics, and Law." [Values in conflict] contains the document "Values in Conflict: Public Attitudes on Embryonic Stem Cell Research." [Additional information (2)] contains additional information submitted.
  • Item
    Human cloning and embryonic stem cell research after Seoul. [Mathews]
    (U.S. Government Printing Office, 2006-03-07) United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.; Mathews, Debra
    Full text of the congressional hearing discussing the ethical issues raised by stem cell research recently conducted in Seoul, South Korea. Issues include human cloning for the purpose of producing human stem cells. [Opening statements] contains the opening statements of the congressional committee. [Battey] contains the testimony and prepared statement of James F. Battey, National Institutes of Health (NIH) Stem Cell Task Force chair. [Schwetz] contains the testimony and prepared statement of Bernard A. Schwetz, director of the Office for Human Research Protections, U.S. Department of Health and Human Services. [Pascal] contains the testimony and prepared statement of Chris B. Pascal, director of the Office of Research Integrity, U.S. Department of Health and Human Services. [Panel 1 questioning] contains the questioning of the first panel, consisting of Battey, Schwetz, and Pascal. [Chole] contains the testimony and prepared statement of stem cell researcher Dr. Richard A. Chole. [Norsigian] contains the testimony and prepared statement of Judy Norsigian, co-author of "Our Bodies Ourselves" and women's health advocate. [Brown] contains the testimony and prepared statement of patient advocate Joe Brown. [Beeson] contains the testimony and prepared statement of Diane Beeson, professor at California State University, East Bay. [Doerflinger] contains the testimony and prepared statement of pro-life advocate Richard M. Doerflinger. [Mathews] contains the testimony and prepared statement of Debra Mathews, scientist and bioethics scholar. [Panel 2 questioning] contains the questioning of the second panel, consisting of Chole, Norsigian, Brown, Beeson, Doerflinger, and Mathews. [Additional information (1)] contains additional information submitted. [Follow-up questions] contains follow-up questions for both panels. [Uniform requirements for manuscripts] contains the document "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication." [Hinxton Group] contains a statement from The Hinxton Group, "An International Consortium on Stem Cells, Ethics, and Law." [Values in conflict] contains the document "Values in Conflict: Public Attitudes on Embryonic Stem Cell Research." [Additional information (2)] contains additional information submitted.
  • Item
    Human cloning and embryonic stem cell research after Seoul. [Chole]
    (U.S. Government Printing Office, 2006-03-07) United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.; Chole, Richard A.
    Full text of the congressional hearing discussing the ethical issues raised by stem cell research recently conducted in Seoul, South Korea. Issues include human cloning for the purpose of producing human stem cells. [Opening statements] contains the opening statements of the congressional committee. [Battey] contains the testimony and prepared statement of James F. Battey, National Institutes of Health (NIH) Stem Cell Task Force chair. [Schwetz] contains the testimony and prepared statement of Bernard A. Schwetz, director of the Office for Human Research Protections, U.S. Department of Health and Human Services. [Pascal] contains the testimony and prepared statement of Chris B. Pascal, director of the Office of Research Integrity, U.S. Department of Health and Human Services. [Panel 1 questioning] contains the questioning of the first panel, consisting of Battey, Schwetz, and Pascal. [Chole] contains the testimony and prepared statement of stem cell researcher Dr. Richard A. Chole. [Norsigian] contains the testimony and prepared statement of Judy Norsigian, co-author of "Our Bodies Ourselves" and women's health advocate. [Brown] contains the testimony and prepared statement of patient advocate Joe Brown. [Beeson] contains the testimony and prepared statement of Diane Beeson, professor at California State University, East Bay. [Doerflinger] contains the testimony and prepared statement of pro-life advocate Richard M. Doerflinger. [Mathews] contains the testimony and prepared statement of Debra Mathews, scientist and bioethics scholar. [Panel 2 questioning] contains the questioning of the second panel, consisting of Chole, Norsigian, Brown, Beeson, Doerflinger, and Mathews. [Additional information (1)] contains additional information submitted. [Follow-up questions] contains follow-up questions for both panels. [Uniform requirements for manuscripts] contains the document "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication." [Hinxton Group] contains a statement from The Hinxton Group, "An International Consortium on Stem Cells, Ethics, and Law." [Values in conflict] contains the document "Values in Conflict: Public Attitudes on Embryonic Stem Cell Research." [Additional information (2)] contains additional information submitted.
  • Item
    Human cloning and embryonic stem cell research after Seoul. [Brown]
    (U.S. Government Printing Office, 2006-03-07) United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.; Brown, Joe
    Full text of the congressional hearing discussing the ethical issues raised by stem cell research recently conducted in Seoul, South Korea. Issues include human cloning for the purpose of producing human stem cells. [Opening statements] contains the opening statements of the congressional committee. [Battey] contains the testimony and prepared statement of James F. Battey, National Institutes of Health (NIH) Stem Cell Task Force chair. [Schwetz] contains the testimony and prepared statement of Bernard A. Schwetz, director of the Office for Human Research Protections, U.S. Department of Health and Human Services. [Pascal] contains the testimony and prepared statement of Chris B. Pascal, director of the Office of Research Integrity, U.S. Department of Health and Human Services. [Panel 1 questioning] contains the questioning of the first panel, consisting of Battey, Schwetz, and Pascal. [Chole] contains the testimony and prepared statement of stem cell researcher Dr. Richard A. Chole. [Norsigian] contains the testimony and prepared statement of Judy Norsigian, co-author of "Our Bodies Ourselves" and women's health advocate. [Brown] contains the testimony and prepared statement of patient advocate Joe Brown. [Beeson] contains the testimony and prepared statement of Diane Beeson, professor at California State University, East Bay. [Doerflinger] contains the testimony and prepared statement of pro-life advocate Richard M. Doerflinger. [Mathews] contains the testimony and prepared statement of Debra Mathews, scientist and bioethics scholar. [Panel 2 questioning] contains the questioning of the second panel, consisting of Chole, Norsigian, Brown, Beeson, Doerflinger, and Mathews. [Additional information (1)] contains additional information submitted. [Follow-up questions] contains follow-up questions for both panels. [Uniform requirements for manuscripts] contains the document "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication." [Hinxton Group] contains a statement from The Hinxton Group, "An International Consortium on Stem Cells, Ethics, and Law." [Values in conflict] contains the document "Values in Conflict: Public Attitudes on Embryonic Stem Cell Research." [Additional information (2)] contains additional information submitted.
  • Item
    Human cloning and embryonic stem cell research after Seoul. [Battey]
    (U.S. Government Printing Office, 2006-03-07) United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.; Battey, James F.
    Full text of the congressional hearing discussing the ethical issues raised by stem cell research recently conducted in Seoul, South Korea. Issues include human cloning for the purpose of producing human stem cells. [Opening statements] contains the opening statements of the congressional committee. [Battey] contains the testimony and prepared statement of James F. Battey, National Institutes of Health (NIH) Stem Cell Task Force chair. [Schwetz] contains the testimony and prepared statement of Bernard A. Schwetz, director of the Office for Human Research Protections, U.S. Department of Health and Human Services. [Pascal] contains the testimony and prepared statement of Chris B. Pascal, director of the Office of Research Integrity, U.S. Department of Health and Human Services. [Panel 1 questioning] contains the questioning of the first panel, consisting of Battey, Schwetz, and Pascal. [Chole] contains the testimony and prepared statement of stem cell researcher Dr. Richard A. Chole. [Norsigian] contains the testimony and prepared statement of Judy Norsigian, co-author of "Our Bodies Ourselves" and women's health advocate. [Brown] contains the testimony and prepared statement of patient advocate Joe Brown. [Beeson] contains the testimony and prepared statement of Diane Beeson, professor at California State University, East Bay. [Doerflinger] contains the testimony and prepared statement of pro-life advocate Richard M. Doerflinger. [Mathews] contains the testimony and prepared statement of Debra Mathews, scientist and bioethics scholar. [Panel 2 questioning] contains the questioning of the second panel, consisting of Chole, Norsigian, Brown, Beeson, Doerflinger, and Mathews. [Additional information (1)] contains additional information submitted. [Follow-up questions] contains follow-up questions for both panels. [Uniform requirements for manuscripts] contains the document "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication." [Hinxton Group] contains a statement from The Hinxton Group, "An International Consortium on Stem Cells, Ethics, and Law." [Values in conflict] contains the document "Values in Conflict: Public Attitudes on Embryonic Stem Cell Research." [Additional information (2)] contains additional information submitted.
  • Item
    Human cloning and embryonic stem cell research after Seoul. [Schwetz]
    (U.S. Government Printing Office, 2006-03-07) United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.; Schwetz, Bernard A.
    Full text of the congressional hearing discussing the ethical issues raised by stem cell research recently conducted in Seoul, South Korea. Issues include human cloning for the purpose of producing human stem cells. [Opening statements] contains the opening statements of the congressional committee. [Battey] contains the testimony and prepared statement of James F. Battey, National Institutes of Health (NIH) Stem Cell Task Force chair. [Schwetz] contains the testimony and prepared statement of Bernard A. Schwetz, director of the Office for Human Research Protections, U.S. Department of Health and Human Services. [Pascal] contains the testimony and prepared statement of Chris B. Pascal, director of the Office of Research Integrity, U.S. Department of Health and Human Services. [Panel 1 questioning] contains the questioning of the first panel, consisting of Battey, Schwetz, and Pascal. [Chole] contains the testimony and prepared statement of stem cell researcher Dr. Richard A. Chole. [Norsigian] contains the testimony and prepared statement of Judy Norsigian, co-author of "Our Bodies Ourselves" and women's health advocate. [Brown] contains the testimony and prepared statement of patient advocate Joe Brown. [Beeson] contains the testimony and prepared statement of Diane Beeson, professor at California State University, East Bay. [Doerflinger] contains the testimony and prepared statement of pro-life advocate Richard M. Doerflinger. [Mathews] contains the testimony and prepared statement of Debra Mathews, scientist and bioethics scholar. [Panel 2 questioning] contains the questioning of the second panel, consisting of Chole, Norsigian, Brown, Beeson, Doerflinger, and Mathews. [Additional information (1)] contains additional information submitted. [Follow-up questions] contains follow-up questions for both panels. [Uniform requirements for manuscripts] contains the document "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication." [Hinxton Group] contains a statement from The Hinxton Group, "An International Consortium on Stem Cells, Ethics, and Law." [Values in conflict] contains the document "Values in Conflict: Public Attitudes on Embryonic Stem Cell Research." [Additional information (2)] contains additional information submitted.
  • Item
    Human cloning and embryonic stem cell research after Seoul. [Opening statements]
    (U.S. Government Printing Office, 2006-03-07) United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.
    Full text of the congressional hearing discussing the ethical issues raised by stem cell research recently conducted in Seoul, South Korea. Issues include human cloning for the purpose of producing human stem cells. [Opening statements] contains the opening statements of the congressional committee. [Battey] contains the testimony and prepared statement of James F. Battey, National Institutes of Health (NIH) Stem Cell Task Force chair. [Schwetz] contains the testimony and prepared statement of Bernard A. Schwetz, director of the Office for Human Research Protections, U.S. Department of Health and Human Services. [Pascal] contains the testimony and prepared statement of Chris B. Pascal, director of the Office of Research Integrity, U.S. Department of Health and Human Services. [Panel 1 questioning] contains the questioning of the first panel, consisting of Battey, Schwetz, and Pascal. [Chole] contains the testimony and prepared statement of stem cell researcher Dr. Richard A. Chole. [Norsigian] contains the testimony and prepared statement of Judy Norsigian, co-author of "Our Bodies Ourselves" and women's health advocate. [Brown] contains the testimony and prepared statement of patient advocate Joe Brown. [Beeson] contains the testimony and prepared statement of Diane Beeson, professor at California State University, East Bay. [Doerflinger] contains the testimony and prepared statement of pro-life advocate Richard M. Doerflinger. [Mathews] contains the testimony and prepared statement of Debra Mathews, scientist and bioethics scholar. [Panel 2 questioning] contains the questioning of the second panel, consisting of Chole, Norsigian, Brown, Beeson, Doerflinger, and Mathews. [Additional information (1)] contains additional information submitted. [Follow-up questions] contains follow-up questions for both panels. [Uniform requirements for manuscripts] contains the document "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication." [Hinxton Group] contains a statement from The Hinxton Group, "An International Consortium on Stem Cells, Ethics, and Law." [Values in conflict] contains the document "Values in Conflict: Public Attitudes on Embryonic Stem Cell Research." [Additional information (2)] contains additional information submitted.
  • Item
    Human cloning and embryonic stem cell research after Seoul. [Additional information (2)]
    (U.S. Government Printing Office, 2006-03-07) United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.
    Full text of the congressional hearing discussing the ethical issues raised by stem cell research recently conducted in Seoul, South Korea. Issues include human cloning for the purpose of producing human stem cells. [Opening statements] contains the opening statements of the congressional committee. [Battey] contains the testimony and prepared statement of James F. Battey, National Institutes of Health (NIH) Stem Cell Task Force chair. [Schwetz] contains the testimony and prepared statement of Bernard A. Schwetz, director of the Office for Human Research Protections, U.S. Department of Health and Human Services. [Pascal] contains the testimony and prepared statement of Chris B. Pascal, director of the Office of Research Integrity, U.S. Department of Health and Human Services. [Panel 1 questioning] contains the questioning of the first panel, consisting of Battey, Schwetz, and Pascal. [Chole] contains the testimony and prepared statement of stem cell researcher Dr. Richard A. Chole. [Norsigian] contains the testimony and prepared statement of Judy Norsigian, co-author of "Our Bodies Ourselves" and women's health advocate. [Brown] contains the testimony and prepared statement of patient advocate Joe Brown. [Beeson] contains the testimony and prepared statement of Diane Beeson, professor at California State University, East Bay. [Doerflinger] contains the testimony and prepared statement of pro-life advocate Richard M. Doerflinger. [Mathews] contains the testimony and prepared statement of Debra Mathews, scientist and bioethics scholar. [Panel 2 questioning] contains the questioning of the second panel, consisting of Chole, Norsigian, Brown, Beeson, Doerflinger, and Mathews. [Additional information (1)] contains additional information submitted. [Follow-up questions] contains follow-up questions for both panels. [Uniform requirements for manuscripts] contains the document "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication." [Hinxton Group] contains a statement from The Hinxton Group, "An International Consortium on Stem Cells, Ethics, and Law." [Values in conflict] contains the document "Values in Conflict: Public Attitudes on Embryonic Stem Cell Research." [Additional information (2)] contains additional information submitted.
  • Item
    Human cloning and embryonic stem cell research after Seoul. [Pascal]
    (U.S. Government Printing Office, 2006-03-07) United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.; Pascal, Chris B.
    Full text of the congressional hearing discussing the ethical issues raised by stem cell research recently conducted in Seoul, South Korea. Issues include human cloning for the purpose of producing human stem cells. [Opening statements] contains the opening statements of the congressional committee. [Battey] contains the testimony and prepared statement of James F. Battey, National Institutes of Health (NIH) Stem Cell Task Force chair. [Schwetz] contains the testimony and prepared statement of Bernard A. Schwetz, director of the Office for Human Research Protections, U.S. Department of Health and Human Services. [Pascal] contains the testimony and prepared statement of Chris B. Pascal, director of the Office of Research Integrity, U.S. Department of Health and Human Services. [Panel 1 questioning] contains the questioning of the first panel, consisting of Battey, Schwetz, and Pascal. [Chole] contains the testimony and prepared statement of stem cell researcher Dr. Richard A. Chole. [Norsigian] contains the testimony and prepared statement of Judy Norsigian, co-author of "Our Bodies Ourselves" and women's health advocate. [Brown] contains the testimony and prepared statement of patient advocate Joe Brown. [Beeson] contains the testimony and prepared statement of Diane Beeson, professor at California State University, East Bay. [Doerflinger] contains the testimony and prepared statement of pro-life advocate Richard M. Doerflinger. [Mathews] contains the testimony and prepared statement of Debra Mathews, scientist and bioethics scholar. [Panel 2 questioning] contains the questioning of the second panel, consisting of Chole, Norsigian, Brown, Beeson, Doerflinger, and Mathews. [Additional information (1)] contains additional information submitted. [Follow-up questions] contains follow-up questions for both panels. [Uniform requirements for manuscripts] contains the document "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication." [Hinxton Group] contains a statement from The Hinxton Group, "An International Consortium on Stem Cells, Ethics, and Law." [Values in conflict] contains the document "Values in Conflict: Public Attitudes on Embryonic Stem Cell Research." [Additional information (2)] contains additional information submitted.
Although these works may be freely accessible on the World Wide Web and may not include any statement about copyright, the U.S. Copyright Act nevertheless provides that such works are protected by copyright. Users must assume that works are protected by copyright until they learn otherwise.